Pierre Morgon

Dr. Pierre A. Morgon, PharmD, LL.M, MBA, is a seasoned leader in the pharmaceutical and biotechnology sectors, currently serving as Co-Founder and Director at Anemos Therapeutics and Non-Executive Director at both Lys Therapeutics and CanSino Biologics Switzerland SA. Dr. Morgon holds key roles at several organizations, including Chief Business Officer at Nuvamid, Board Member at the International Alliance for Biological Standardization (IABS), and independent Non-Executive Director at Zambon Biotech. With a strong educational foundation that includes a Doctorate of Pharmacy and multiple advanced degrees in business and law, Dr. Morgon has demonstrated expertise in financing, governance, and partnering strategies across various companies, driving innovation and strategic leadership in the industry.